Víctor Gómez‐Mayordomo

ORCID: 0000-0001-9343-8439
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Long-Term Effects of COVID-19
  • COVID-19 and Mental Health
  • Parkinson's Disease Mechanisms and Treatments
  • Fibromyalgia and Chronic Fatigue Syndrome Research
  • Botulinum Toxin and Related Neurological Disorders
  • Neurological disorders and treatments
  • Migraine and Headache Studies
  • Pain Mechanisms and Treatments
  • Psychosomatic Disorders and Their Treatments
  • Genetic Neurodegenerative Diseases
  • Restless Legs Syndrome Research
  • COVID-19 Clinical Research Studies
  • Musculoskeletal pain and rehabilitation
  • Trigeminal Neuralgia and Treatments
  • Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
  • Peripheral Neuropathies and Disorders
  • Neurological diseases and metabolism
  • Intensive Care Unit Cognitive Disorders
  • Sympathectomy and Hyperhidrosis Treatments
  • Dysphagia Assessment and Management
  • Ginkgo biloba and Cashew Applications
  • Maternal Mental Health During Pregnancy and Postpartum
  • Cardiac pacing and defibrillation studies
  • Heart Failure Treatment and Management
  • Ultrasound and Hyperthermia Applications

Hospital Clínico San Carlos
2018-2023

Neurosciences Institute
2023

Instituto de Investigación Sanitaria del Hospital Clínico San Carlos
2018-2022

Hospital Universitario Fundación Jiménez Díaz
2022

Universidad Complutense de Madrid
2018-2022

Universidad Rey Juan Carlos
2021

American Headache Society
2020

New York Proton Center
2020

The pandemic of the coronavirus disease 2019 (COVID-19) has provoked a second pandemic, "long-haulers", i.e., individuals presenting with post-COVID symptoms. We propose that to determine presence symptoms, symptoms should appear after diagnosis SARS-CoV-2 infection; however, this situation some problems due fact not all people infected by receive such diagnosis. Based on relapsing/remitting nature following integrative classification is proposed: potentially infection related-symptoms (up...

10.3390/ijerph18052621 article EN International Journal of Environmental Research and Public Health 2021-03-05

This multicenter cohort study investigated the differences between coronavirus disease 2019 (COVID-19) related symptoms and post-COVID male female COVID-19 survivors. Clinical hospitalization data were collected from hospital medical records in a sample of individuals recovered at five public hospitals Spain. A predefined list was systematically assessed, but patients free to report any symptom. Anxiety/depressive levels sleep quality also assessed. Adjusted multivariate logistic regressions...

10.3390/jcm11020413 article EN Journal of Clinical Medicine 2022-01-14

<b><i>Background:</i></b> Multicentre studies focussing on specific long-term post-COVID-19 symptoms are scarce. <b><i>Objective:</i></b> The aim of this study was to determine the levels fatigue and dyspnoea, repercussions daily life activities, risk factors associated with or dyspnoea in COVID-19 survivors at long term after hospital discharge. <b><i>Methods:</i></b> Age, gender, height, weight, hospitalization,...

10.1159/000518854 article EN other-oa Respiration 2021-09-21

Abstract This study investigated the prevalence of long-term musculoskeletal post-COVID pain and their risk factors in a large cohort COVID-19 survivors. A multicenter including patients hospitalised because 5 hospitals Madrid (Spain) during first wave pandemic was conducted. Hospitalisation clinical data were collected from medical records. Patients scheduled for telephone interview after hospital discharge collecting about pain. Anxiety/depressive levels sleep quality likewise assessed....

10.1097/j.pain.0000000000002564 article EN Pain 2021-12-10

Objective To investigate the association of headache during acute phase SARS-CoV-2 infection with long-term post-COVID and other symptoms in hospitalised survivors. Methods A case-control study including patients first wave pandemic Spain was conducted. Patients reporting as a symptom age- sex-matched without participated. Hospitalisation clinical data were collected from medical records. scheduled for telephone interview 7 months after hospital discharge. Participants asked about list also...

10.1177/03331024211020404 article EN cc-by Cephalalgia 2021-06-16

Abstract This study investigated the association between COVID-related myalgia experienced by patients at hospital admission and presence of post-COVID symptoms. A case-control including hospitalised due to COVID-19 February 20 May 31, 2020, was conducted. Patients reporting without were scheduled for a telephone interview 7 months after discharge. Hospitalisation clinical data collected from medical records. list symptoms with attention musculoskeletal pain evaluated. Anxiety depressive...

10.1097/j.pain.0000000000002306 article EN Pain 2021-04-08

This study compared associated-symptoms at the acute phase of infection and post-COVID-19 symptoms between individuals hospitalized with Wuhan, Alpha or Delta SARS-CoV-2 variant. Non-vaccinated because in one hospital during three different waves pandemic (Wuhan, Delta) were scheduled for a telephone interview. The presence was systematically assessed. Hospitalization clinical data collected from medical records. A total 201 patients infected Wuhan variant, 211 variant 202 assessed six...

10.3390/pathogens11070725 article EN cc-by Pathogens 2022-06-25

Background and objective: Sex plays a role in Parkinson’s disease (PD) mechanisms. We analyzed sex difference manifestations among Spanish patients with PD. Patients Methods: PD who were recruited from the cohort COPPADIS January 2016 to November 2017 included. A cross-sectional two-year follow-up analysis conducted. Univariate analyses general linear model repeated measure used. Results: At baseline, data 681 (mean age 62.54 ± 8.93) fit criteria for analysis. Of them, 410 (60.2%) males 271...

10.3390/jcm12041329 article EN Journal of Clinical Medicine 2023-02-07

The role of disease-modifying therapies in patients with autoimmune disorders during severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) infection is controversial. Immunocompromised could have a more disease-2019 (COVID-19) due to the absence an adequate immune response against SARS-CoV-2. However, that act on play protective by dampening cytokine-release syndrome. Fingolimod drug used for therapy multiple sclerosis (MS) through sequestration activated lymphocytes lymph nodes. We...

10.1002/jmv.26279 article EN Journal of Medical Virology 2020-07-09
Diego Santos‐García Teresa de Deus Fonticoba Carlos Cores Guillermo Muńoz Jose M. Paz González and 95 more Cristina Martínez Miró Ester Suárez Silvia Jesús Miquel Aguilar Pau Pástor Lluís Planellás Marina Cosgaya Juan García Caldentey Núria Caballol I. Legarda Jorge Hernández‐Vara Iria Cabo Lydia López Manzanares Isabel González Aramburu María A. Ávila Rivera María José Catalán Víctor Nogueira Víctor Puente M. Ruíz De Arcos Carmen Borrué Berta Solano Vila María Álvarez Saúco Lydia Vela Sonia Escalante Esther Cubo Francisco Carrillo Padilla Juan Carlos Martínez‐Castrillo Pilar Sánchez Alonso Maria G. Alonso Losada Nuria López Ariztegui Itziar Gastón Pedro Clavero Jaime Kulisevsky Marta Blázquez Estrada Manuel Seijo Javier Ruiz‐Martínez Caridad Valero Mónica Kurtis Oriol de Fàbregues Jessica González Ardura Carlos Ordás Luis M. López Díaz Darrian McAfee Pablo Martínez‐Martín Pablo Mir Daniela A. Adarmes Marta Almería A. Alonso Cánovas F. Alonso Frech Ruben Alonso Redondo Ignacio Álvarez Ángel Aneiros Díaz S. Arnáiz Sonia López Arribas A. Ascunce Vidondo N. Bernardo Lambrich H. Bejr-Kasem M. Botí Maríateresa Buongiorno C. Cabello González A. Cámara Lorenzo H. Canfield Medina Fátima Carrillo Erik Jesús Huánuco Casas A. Cortina Fernández A. Cots Foraster A. Crespo Cuevas Mónica Díez-Fairén Julio Dotor García‐Soto Elena Erro E. Estelrich Peyret N. Fernández Guillán P. Gámez Mercedes Gallego Cristina Campos J M García-Moreno M. P. Gómez Garre Víctor Gómez‐Mayordomo J. González Aloy B. González García M. J. González Palmás G. R. González Toledo Raquel Gabriel Ana Golpe Díaz M. Grau Solá G. Guardia Andrea Horta‐Barba Daniel Idoate Calderón Jon Infante Carmen M. Labandeira M. A. Labrador Francisco Agramunt Lacruz M. Lage Castro S. Lastres Gómez B. López Seoane

Quality of life (QOL) plays an important role in independent living Parkinson's disease (PD) patients, being crucial to know what factors impact QoL throughout the course disease. Here we identified predictors impairment PD patients from a Spanish cohort. recruited 35 centers Spain COPPADIS cohort January 2016, November 2017, were followed up during 2 years. Health-related (HRQoL) and global (GQoL) assessed with 39-item Questionnaire (PDQ-39) EUROHIS-QOL 8-item index (EUROHIS-QOL8),...

10.1038/s41531-021-00256-w article EN cc-by npj Parkinson s Disease 2021-12-16

Objective To investigate the association of pre-existing migraine in patients hospitalised and who recovered from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection with presence post-coronavirus disease (COVID) symptoms. Background No study has investigated role as a risk factor for development post-COVID Methods A case-control including individuals during first wave pandemic (from February 20 to May 31, 2020) was conducted. Patients confirmed previous diagnosis were...

10.3389/fnhum.2021.678472 article EN cc-by Frontiers in Human Neuroscience 2021-06-28

We compared the prevalence of musculoskeletal post-COVID pain between previously hospitalized COVID-19 survivors infected with historical, Alpha or Delta SARS-CoV-2 variant. Data about were systematically collected through a telephone interview involving 201 patients who had survived historical variant, 211 variant and 202 six months after hospital discharge. Participants recruited from non-vaccinated individuals due to infection in one Madrid (Spain) during three different waves pandemic...

10.3390/biomedicines10081951 article EN cc-by Biomedicines 2022-08-11

Directional subthalamic stimulation in Parkinson's disease can increase threshold for adverse effects and widen the therapeutic window. However, selection of programming settings is time consuming, requiring a thorough monopolar clinical review. To overcome this, may be guided by intraoperatively recording local field potential beta oscillations (13-35 Hz).1) Evaluate whether power recorded predict clinically most effective directional contacts; 2) assess long-term outcomes between patients...

10.1016/j.brs.2022.04.015 article EN cc-by-nc-nd Brain stimulation 2022-04-28

This study looked at differences in the presence of headache as an onset symptom coronavirus disease 2019 (COVID-19) and a post-COVID-19 individuals previously hospitalized owing to infection with Wuhan, Alpha, or Delta variants severe acute respiratory syndrome 2 (SARS-CoV-2).Headache can be present up 50% during phase SARS-CoV-2 10% subjects phase. There are no data on occurrence acute- according variants.A cross-sectional cohort was conducted. Unvaccinated for COVID-19 caused by Wuhan (n...

10.1111/head.14398 article EN cc-by-nc Headache The Journal of Head and Face Pain 2022-09-16

Constipation has been linked to cognitive impairment development in Parkinson's disease (PD).Our aim was analyze changes observed PD patients and controls from a Spanish cohort with regards the presence or not of constipation.PD recruited 35 centers Spain COPPADIS January 2016 November 2017 were followed-up during 2 years. The change status baseline (V0) 2-year follow-up assessed PD-CRS (Parkinson's Disease Cognitive Rating Scale). Subjects score ≥1 on item 21 NMSS (Non-Motor Symptoms Scale)...

10.3233/jpd-212868 article EN Journal of Parkinson s Disease 2021-10-02

Abstract This study investigated the association between serological biomarkers at hospital admission with development of long-term post-COVID pain symptoms in previously hospitalized coronavirus disease, 2019 (COVID-19) survivors. A cohort including patients hospitalised because COVID-19 1 urban Madrid (Spain) during first wave outbreak was conducted. Hospitalisation data, clinical and 11 were collected admission. Participants scheduled for an individual telephone interview after discharge...

10.1097/j.pain.0000000000002608 article EN Pain 2022-02-03

Deep brain stimulation (DBS) is widely used for treatment of advanced, medication-refractory Parkinson's disease (PD). However, a significant proportion patients may suffer adverse effects; up to 10% will present one or more transient permanent neurobehavioral events.In our case study, 44-year-old woman diagnosed with PD 6 years previously who was suffering from motor fluctuations, dyskinesia, and freezing gait episodes submitted DBS implanted directional electrodes. Intraoperative local...

10.3389/fneur.2021.786166 article EN cc-by Frontiers in Neurology 2022-01-31

Objectives This study aimed to explore the views and experiences of a group Spanish patients suffering from new daily persistent headache (NDPH). Methods A qualitative descriptive was conducted with diagnosed NDPH. Purposeful sampling performed among attending specialized Headache Unit at 2 university hospitals between February 2017 December 2018. In total, 18 (11 women, 7 men; mean age 45.3, standard deviation 10.6) median duration illness 70 months (interquartile range, 24‐219) were...

10.1111/head.13712 article EN Headache The Journal of Head and Face Pain 2019-11-26
Coming Soon ...